Qilian International Holding (QLI): Aggregate Debt Obligations

Brandmark of Qilian International Holding (QLI)

The visualization of the market price for Qilian International (QLI) individual debt on the GURU.Markets platform demonstrates metrics at the level of 0.00. Qilian International (QLI) is fighting for influence in the chemical raw materials segment, trailing state-owned entities. The business relies on the production of components for medicine and traditional remedies in the PRC, where cash flows are stable but dependent on government contracts. Control over the value chain for heparin and licorice extracts provides a competitive advantage.

QLI Qilian International Holding Group Limited: Company Aggregate Debts in the range 07/04/2022 - 08/17/2024
Finished products of Qilian International

Stable licenses held by Qilian International (QLI) provide a market priority, yet the necessity of upgrading plants to meet environmental standards requires a significant influx of capital. Analyzing the debt movement chart, an investor can observe the dynamics of total liabilities by comparing credit offerings with the company's demand for loans, which allows for an assessment of default risk and the stability of the issuer's capitalization during periods of macroeconomic instability.

Competing companies

Company Aggregate Debts Haleon Corp (HLN)|Company Debts Kenvue Inc. KVUE|Aggregate Debt Obligations VRNA|MENS - Company Debts|Ligand Pharmaceuticals Incorporated (LGND) - Company Total Debt|AMRX: Company Aggregate Debts|Perrigo Corp (PRGO) - Company Aggregate Debts|Company Total Debt ALVO|LQDA: Aggregate Debt Obligations|Company Debts Galapagos (GLPG)|ANIP - Company Cumulative Debt|MannKind Corp. - Company Total Debt|Company Cumulative Indebtedness AMPH (Amphastar Corp)|Pacira BioSciences - Company Aggregate Debts|Aggregate Debt Obligations SPRY (ars-pharma.com)|TBPH: Company Aggregate Debts|Company Cumulative Debt Aquestive Therapeutics Inc (AQST)|Company Debts scPharmaceuticals, Inc.|TECX: Aggregate Debt Obligations|Company Debts Tonix Pharmaceuticals (TNXP)|sxtchina.com (SXTC) - Company Total Indebtedness|Company Aggregate Debts EPRX (Eupraxia Pharmaceuticals Inc.)|Company Total Debt Obligations BioHarvest Sciences, Inc. (BHST)|EXOZ - Company Debts|ORMP: Company Debts|ENTX: Company Aggregate Debts|HYFT - Company Total Debt Obligations|ABVC (ABVC BioPharma, Inc.) - Company Aggregate Debts|Company Aggregate Debts Cumberland Pharmaceuticals Inc|Company Debts Quantum BioPharma Limited (QNTM)|FibroGen Corporation - Company Aggregate Debt|Telomir Pharmaceuticals - Company Total Debt|Aggregate Debt Obligations RANI|Synergy CHC Corporation - Company Aggregate Debts|Company Total Debt Obligations Rallybio Corporation RLYB|lexariabioscience.com (LEXX) - Company Debts|Company Aggregate Debt PULM|Company Total Debt PTHL|APM (Aptorum) - Company Cumulative Indebtedness|Company Aggregate Debts LYRA|IBO - Company Cumulative Debt|Company Debts TNF Pharmaceuticals, Inc. TNFA|Aggregate Debt Obligations YCBD|PRFX - Company Debts|CYTO (Altamira Therapeutics) - Company Aggregate Debt|LIPO: Company Aggregate Debts|OptiNose Inc (OPTN) - Company Aggregate Debts|Company Total Debt PIRS|PROC (Procaps Group Corp) - Company Cumulative Indebtedness|Company Aggregate Debts PTPI|Company Total Debt Obligations acelyrin.com|Company Debts TFF Pharmaceuticals, Inc. TFFP